Archean Chemical Industries Limited (NSE:ACI)
India
· Delayed Price · Currency is INR | Market Cap | 75.04B |
| Revenue (ttm) | 11.26B |
| Net Income (ttm) | 1.46B |
| Shares Out | 123.46M |
| EPS (ttm) | 11.86 |
| PE Ratio | 51.24 |
| Forward PE | 26.92 |
| Dividend | 3.00 (0.50%) |
| Ex-Dividend Date | n/a |
| Volume | 18,064 |
| Average Volume | 147,481 |
| Open | 607.80 |
| Previous Close | 607.80 |
| Day's Range | 607.80 - 617.10 |
| 52-Week Range | 483.00 - 727.60 |
| Beta | 0.35 |
| RSI | 59.54 |
| Earnings Date | Apr 30, 2026 |
About NSE:ACI
Archean Chemical Industries Limited manufactures and sells specialty marine chemicals in India and internationally. It offers bromine for use in pharmaceuticals, agrochemicals, flame retardants, and water treatment products, as well as oil and gas, and energy storage industries; industrial salt for chloralkali chemical, food and beverage, water treatment, and oil and gas industries; and sulphate of potash, an inorganic salt for agrochemicals, medical, glass, cosmetics, and medical users industries. The company was founded in 2003 and is based i... [Read more]
Financial Performance
In fiscal year 2025, NSE:ACI's revenue was 10.41 billion, a decrease of -21.73% compared to the previous year's 13.30 billion. Earnings were 1.62 billion, a decrease of -49.17%.
Financial StatementsNews
Archean Chemical Industries Transcript: Q3 25/26
Q3 saw modest revenue growth and margin pressure due to higher costs and operational challenges, but demand for bromine and industrial salt remains robust. Strategic projects in semiconductors and energy storage are progressing, with SOP and derivatives businesses expected to ramp up in FY27.
Archean Chemical Industries Transcript: Q2 25/26
Revenue grew 10% year-over-year in H1 FY 2026 despite monsoon and macro headwinds, with strong demand for bromine and industrial salt. Major milestones include India Semiconductor Mission approval and progress in energy storage and SOP. Net profit rose 28% year-over-year.
Archean Chemical Industries Transcript: Q1 25/26
Q1 FY26 delivered 30% YOY revenue growth, with strong performance in bromine and industrial salt, and robust margins. Strategic projects in SOP, bromine derivatives, and energy storage are progressing, while guidance for core segments remains intact.
Archean Chemical Industries Transcript: Q4 24/25
Q4 and FY2025 saw strong revenue and margin performance, with robust growth in bromine and industrial salt segments. Strategic investments in derivatives, semiconductors, and energy storage, plus disciplined capital allocation, position the company for continued growth.
Archean Chemical Industries Transcript: Q3 24/25
Q3 FY25 saw sequential revenue and profit growth, with strong EBITDA margins and a healthy order book despite global headwinds. Strategic investments in semiconductors and energy storage, along with ramp-up in derivatives and new acquisitions, position the company for robust FY26 growth.
Archean Chemical Industries Transcript: Q2 24/25
Revenue and profit declined year-over-year due to weather and logistics disruptions, but core marine chemicals remain strong. Strategic investments in semiconductors and energy storage are underway, with cautious optimism for bromine and salt volume recovery in H2.
Archean Chemical Industries Transcript: Q1 24/25
Q1 FY25 revenue dropped 37% year-over-year due to logistics issues, but EBITDA margin held at 38% and net profit was INR 285 million. Management expects recovery as demand and contracts remain strong, with new product and acquisition contributions anticipated in H2 FY25.